• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    Albany Molecular Research Inc. (AMRI)

    -NasdaqGS
    16.24 0.02(0.12%) Jan 28, 4:00PM EST
    Add to Portfolio
    Prev Close:16.22
    Open:16.35
    Bid:N/A
    Ask:18.28 x 200
    1y Target Est:20.50
    Beta:1.19
    Earnings Date:Feb 10 - Feb 16 (Est.)
    Day's Range:16.15 - 16.43
    52wk Range:10.28 - 23.95
    Volume:251,419
    Avg Vol (3m):644,656
    Market Cap:514.30M
    P/E (ttm):145.00
    EPS (ttm):0.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AMRI

    Comparison

    Symbol% ChgMkt Cap
    AMRIUp 0.12%514.30M
    CVD6.03B
    Q7.88B

    Key Statistics

    Forward P/E (1 yr):18.04
    P/S (ttm):2.00
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.68
    Quarterly EPS Est (Dec-14) :0.33
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback